AROMICS is a biotechnology company specialized in the identification of molecular markers in the context of unmet clinical needs, and the development of innovative diagnostics and novel therapies once validated. Over last years, the company has been working with for profit and non-profit organizations, to identify and validate targets, qualify leads, as well as complete proof-of-concept in vitro and in vivo studies and early toxicology and ADME studies, ultimately leading to INDs.
Type of supplier
Biotechnology Company - Therapeutics, Biotechnology R&D Company - Diagnostics / Devices and Diagnostics Services
Sector of activity:
Biomarkers / Biomarker Discovery, Cancer / Oncology, Drug Discovery / Research & Development, Infectious diseases, Molecular biology